Objective: Fetal growth restriction (FGR) is a serious pathological complication associated with perinatal death and adverse pregnancy outcomes, which is largely related to placental dysfunction. This study aimed to identify FGR-related placenta transcriptomic features and provide insight into the pathologic mechanisms of FGR.
Methods: In this research, transcriptomic data were obtained by RNA sequencing on placenta samples from eight FGR patients and eight normal term-pregnant women. Differential expression analysis was used to identify the differentially expressed genes (DEGs) between groups, then function and pathway enrichment analysis by DEGs was performed. After correlation analysis between DEGs and clinical indicators of FGR, validation of DEGs by Gene Expression Omnibus (GEO) dataset was carried out. Receiver operating characteristic (ROC) analysis was used to calculate the diagnostic ability of DEG biomarkers.
Results: We identified seven candidate DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed candidate DEGs primarily involved in chemokine activities and lymphocyte chemotaxis. Correlation analysis found that the expression level of DPPA4 and CTAG2 gene were significantly positively correlated with neonatal birth weight (p < 0.05). The expression level of IGSF21 was significantly negatively correlated with placenta weight, neonatal birth weight and neonatal birth weight percentile (p < 0.05). The expression level of CXCL11 showed a negative correlation with neonatal birth weight and neonatal birth weight percentile (p < 0.05). Additionally, the expression level of CXCL10 exhibited a negative correlation to neonatal birth weight percentile (p < 0.05). The expression level of HLA-DQA1, CXCL10 and CXCL11 in the GEO dataset were in good agreement with our results. We conducted the ROC analysis and found the area under the curve (AUC) values based on each DEG alone were 80% for HLA-DQA1, 79%f or CXCL11 and 76% for CXCL10, suggesting that the above three DEGs had potential significance for FGR diagnosis.
Conclusion: This study gives an insight into transcriptional features in FGR mechanism and discovers novel genes that may provide evidence for predicting and managing FGR.
{"title":"Placental transcriptomic profiling showed disturbance of chemokine activities and lymphocyte chemotaxis in pregnancy with fetal growth restriction.","authors":"Xiaohui Li, Xin He, Jiamei Tong, Yanan Hu, Zhengpeng Li, Yi Chen","doi":"10.1080/14767058.2025.2567473","DOIUrl":"https://doi.org/10.1080/14767058.2025.2567473","url":null,"abstract":"<p><strong>Objective: </strong>Fetal growth restriction (FGR) is a serious pathological complication associated with perinatal death and adverse pregnancy outcomes, which is largely related to placental dysfunction. This study aimed to identify FGR-related placenta transcriptomic features and provide insight into the pathologic mechanisms of FGR.</p><p><strong>Methods: </strong>In this research, transcriptomic data were obtained by RNA sequencing on placenta samples from eight FGR patients and eight normal term-pregnant women. Differential expression analysis was used to identify the differentially expressed genes (DEGs) between groups, then function and pathway enrichment analysis by DEGs was performed. After correlation analysis between DEGs and clinical indicators of FGR, validation of DEGs by Gene Expression Omnibus (GEO) dataset was carried out. Receiver operating characteristic (ROC) analysis was used to calculate the diagnostic ability of DEG biomarkers.</p><p><strong>Results: </strong>We identified seven candidate DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed candidate DEGs primarily involved in chemokine activities and lymphocyte chemotaxis. Correlation analysis found that the expression level of <i>DPPA4</i> and <i>CTAG2</i> gene were significantly positively correlated with neonatal birth weight (<i>p</i> < 0.05). The expression level of <i>IGSF21</i> was significantly negatively correlated with placenta weight, neonatal birth weight and neonatal birth weight percentile (<i>p</i> < 0.05). The expression level of <i>CXCL11</i> showed a negative correlation with neonatal birth weight and neonatal birth weight percentile (<i>p</i> < 0.05). Additionally, the expression level of <i>CXCL10</i> exhibited a negative correlation to neonatal birth weight percentile (<i>p</i> < 0.05). The expression level of <i>HLA-DQA1</i>, <i>CXCL10</i> and <i>CXCL11</i> in the GEO dataset were in good agreement with our results. We conducted the ROC analysis and found the area under the curve (AUC) values based on each DEG alone were 80% for <i>HLA-DQA1</i>, 79%f or <i>CXCL11</i> and 76% for <i>CXCL10</i>, suggesting that the above three DEGs had potential significance for FGR diagnosis.</p><p><strong>Conclusion: </strong>This study gives an insight into transcriptional features in FGR mechanism and discovers novel genes that may provide evidence for predicting and managing FGR.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2567473"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-12-03DOI: 10.1080/14767058.2025.2592375
Isaura Molina Stornelli, Nikolay Bliznyuk, Juan Carlos Roig, Josef Neu, Katherine Kisilewicz, Dhanashree Rajderkar, Livia Sura, Sujal Patel, Daniel Chong, Siena Vadakal, Taylor Edwards, Michael D Weiss
Background: Therapeutic hypothermia (TH) is standard of care for neonates ≥36 weeks with hypoxic-ischemic encephalopathy (HIE). Although intravenous fluid restriction is common, optimal strategies for parenteral and enteral nutrition remain unclear. This study evaluated the tolerance of parenteral nutrition (PN) and enteral feeding in neonates undergoing TH, as well as the impact of these interventions on clinical outcomes.
Methods: We retrospectively reviewed charts from the Florida Neonatal Neurologic Network (FN3) of neonates who underwent TH for HIE between 2012 and 2020. Collected data included demographics, neurologic assessments, nutritional strategies, laboratory values, and MRI findings. Statistical analysis was performed using one-way ANOVA, with results expressed as Kruskal-Wallis p-values.
Results: Of 170 neonates, 163 met inclusion criteria. Participants were categorized by nutritional approach: intravenous fluids (IVF), PN, or both. Neonates receiving PN had significantly higher blood urea nitrogen (BUN) during TH (p < 0.05), although values remained within acceptable limits. Lipid tolerance did not differ between groups. PN administration was associated with improved glucose regulation at 12 h (p < 0.05). Enteral feeding correlated with reduced brain injury on MRI and improved neurodevelopmental outcomes, including cognitive (p < 0.05) and motor (p < 0.05) function. Neonates receiving both PN and enteral feeding demonstrated significant recovery from malnutrition by the first outpatient follow-up (p < 0.05) and achieved full enteral feeds sooner (p < 0.05).
Conclusions: Early nutritional support, including PN and enteral feeding, appears to be well-tolerated in neonates undergoing TH for HIE. These findings suggest that providing early nutrition may enhance neurodevelopmental outcomes and promote growth during TH.
{"title":"Nutrition in infants with hypoxic-ischemic encephalopathy: insights from a single-center experience on parenteral and enteral feeding during therapeutic hypothermia.","authors":"Isaura Molina Stornelli, Nikolay Bliznyuk, Juan Carlos Roig, Josef Neu, Katherine Kisilewicz, Dhanashree Rajderkar, Livia Sura, Sujal Patel, Daniel Chong, Siena Vadakal, Taylor Edwards, Michael D Weiss","doi":"10.1080/14767058.2025.2592375","DOIUrl":"https://doi.org/10.1080/14767058.2025.2592375","url":null,"abstract":"<p><strong>Background: </strong>Therapeutic hypothermia (TH) is standard of care for neonates ≥36 weeks with hypoxic-ischemic encephalopathy (HIE). Although intravenous fluid restriction is common, optimal strategies for parenteral and enteral nutrition remain unclear. This study evaluated the tolerance of parenteral nutrition (PN) and enteral feeding in neonates undergoing TH, as well as the impact of these interventions on clinical outcomes.</p><p><strong>Methods: </strong>We retrospectively reviewed charts from the Florida Neonatal Neurologic Network (FN3) of neonates who underwent TH for HIE between 2012 and 2020. Collected data included demographics, neurologic assessments, nutritional strategies, laboratory values, and MRI findings. Statistical analysis was performed using one-way ANOVA, with results expressed as Kruskal-Wallis p-values.</p><p><strong>Results: </strong>Of 170 neonates, 163 met inclusion criteria. Participants were categorized by nutritional approach: intravenous fluids (IVF), PN, or both. Neonates receiving PN had significantly higher blood urea nitrogen (BUN) during TH (<i>p</i> < 0.05), although values remained within acceptable limits. Lipid tolerance did not differ between groups. PN administration was associated with improved glucose regulation at 12 h (<i>p</i> < 0.05). Enteral feeding correlated with reduced brain injury on MRI and improved neurodevelopmental outcomes, including cognitive (<i>p</i> < 0.05) and motor (<i>p</i> < 0.05) function. Neonates receiving both PN and enteral feeding demonstrated significant recovery from malnutrition by the first outpatient follow-up (<i>p</i> < 0.05) and achieved full enteral feeds sooner (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>Early nutritional support, including PN and enteral feeding, appears to be well-tolerated in neonates undergoing TH for HIE. These findings suggest that providing early nutrition may enhance neurodevelopmental outcomes and promote growth during TH.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2592375"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-02DOI: 10.1080/14767058.2025.2578576
Bridget Galati, Heather Jacobsen, Melissa Kraus, Melissa Mills, Brittaney Vaughn, Sam Williams, Michael Wenzinger, Cynthia Rogers, Nandini Raghuraman, Jeannie Kelly
<p><strong>Objective: </strong>The late postpartum period, defined as greater than 6 weeks to 12 months, is a high-risk time for individuals with opioid use disorder (OUD). Discontinuation rates of buprenorphine treatment for OUD during this period are high. Little is known about patients' subjective experience with buprenorphine treatment during this time. We sought to assess patient treatment experience, goals, facilitators and barriers to continued buprenorphine treatment throughout the extended postpartum period.</p><p><strong>Methods: </strong>We performed a cross-sectional survey of postpartum patients who received buprenorphine treatment, including sublingual and long-acting injectable formulations, in an interdisciplinary, wrap-around clinic for maternal OUD between February 2022 through May 2023. Individuals participated in a brief electronic questionnaire comprised of multiple choice, Likert scale and open-ended questions adapted from validated surveys. Individuals were recruited to participate at each of three separate time points postpartum; <6 weeks, ≥6 weeks to 3 months, and >3 months. Descriptive statistics, Fisher exact, the Cochran-Armitage trend and chi-squared tests were used to describe survey results.</p><p><strong>Results: </strong>Fifty individuals were approached to participate in the survey, of which 25 unique postpartum individuals participated. This captured a total of 37 responses amongst all three time points. At the time of final survey completion, the average individual was 10.68 months (SD ± 7.13) postpartum. 76% self-identified as white and 24% Black or African American. The majority (88%) were prescribed sublingual buprenorphine. Most (84%) had been prescribed buprenorphine for more than three months at the time of initial survey completion. The majority (89%) of responses across all time points reported being very satisfied or satisfied with their current treatment, being satisfied with the effectiveness of their buprenorphine in reducing opioid use (98%) and with the effectiveness at reducing other substance use (54%). Top motivators for continuing treatment included individual health, ability to care for child(ren), and social support of friends or family. No differences were detected across time points. Surprisingly, the most often reported treatment goal was to discontinue buprenorphine eventually (49% of all responses). Most strongly agreed or agreed with the following statements about social supports, including that they know they take buprenorphine (100%), support their decision to take buprenorphine (89%), believe it is treatment for OUD (78%), and want them to continue treatment (78%). However, fewer (41%) strongly agreed or agreed with the following statement: the people I am close to want me to continue buprenorphine treatment long term (i.e. several years). Less than half (46%) agreed with the statement, the people I am close to know what it takes to stay sober. Barriers to buprenorphine treatment we
{"title":"Buprenorphine treatment during the extended postpartum period: a survey of patient experiences.","authors":"Bridget Galati, Heather Jacobsen, Melissa Kraus, Melissa Mills, Brittaney Vaughn, Sam Williams, Michael Wenzinger, Cynthia Rogers, Nandini Raghuraman, Jeannie Kelly","doi":"10.1080/14767058.2025.2578576","DOIUrl":"https://doi.org/10.1080/14767058.2025.2578576","url":null,"abstract":"<p><strong>Objective: </strong>The late postpartum period, defined as greater than 6 weeks to 12 months, is a high-risk time for individuals with opioid use disorder (OUD). Discontinuation rates of buprenorphine treatment for OUD during this period are high. Little is known about patients' subjective experience with buprenorphine treatment during this time. We sought to assess patient treatment experience, goals, facilitators and barriers to continued buprenorphine treatment throughout the extended postpartum period.</p><p><strong>Methods: </strong>We performed a cross-sectional survey of postpartum patients who received buprenorphine treatment, including sublingual and long-acting injectable formulations, in an interdisciplinary, wrap-around clinic for maternal OUD between February 2022 through May 2023. Individuals participated in a brief electronic questionnaire comprised of multiple choice, Likert scale and open-ended questions adapted from validated surveys. Individuals were recruited to participate at each of three separate time points postpartum; <6 weeks, ≥6 weeks to 3 months, and >3 months. Descriptive statistics, Fisher exact, the Cochran-Armitage trend and chi-squared tests were used to describe survey results.</p><p><strong>Results: </strong>Fifty individuals were approached to participate in the survey, of which 25 unique postpartum individuals participated. This captured a total of 37 responses amongst all three time points. At the time of final survey completion, the average individual was 10.68 months (SD ± 7.13) postpartum. 76% self-identified as white and 24% Black or African American. The majority (88%) were prescribed sublingual buprenorphine. Most (84%) had been prescribed buprenorphine for more than three months at the time of initial survey completion. The majority (89%) of responses across all time points reported being very satisfied or satisfied with their current treatment, being satisfied with the effectiveness of their buprenorphine in reducing opioid use (98%) and with the effectiveness at reducing other substance use (54%). Top motivators for continuing treatment included individual health, ability to care for child(ren), and social support of friends or family. No differences were detected across time points. Surprisingly, the most often reported treatment goal was to discontinue buprenorphine eventually (49% of all responses). Most strongly agreed or agreed with the following statements about social supports, including that they know they take buprenorphine (100%), support their decision to take buprenorphine (89%), believe it is treatment for OUD (78%), and want them to continue treatment (78%). However, fewer (41%) strongly agreed or agreed with the following statement: the people I am close to want me to continue buprenorphine treatment long term (i.e. several years). Less than half (46%) agreed with the statement, the people I am close to know what it takes to stay sober. Barriers to buprenorphine treatment we","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2578576"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145432903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Postpartum psychiatric disorders (PPDs) have been deemed as a significant public health concern, affecting both maternal health and family dynamics. This study aimed to examine the current status of PPDs, identify the potential risk factors of PPDs, and further develop a clinical nomogram model for predicting PPDs in Chinese women.
Method: In this retrospective cohort study, 1418 postpartum women attending the routine postpartum examination at the 42nd day after delivery in Jiangsu Women and Children Health Hospital were recruited as participants from December 2020 to December 2022. The Symptom Checklist-90 (SCL-90) was utilized to assess the status of postpartum psychiatric disorders. A prediction model was constructed by multivariate logistic regression and presented as a nomogram. The performance of nomogram was measured by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA). The relationships between predictive factors of PPDs and SCL-90 were also evaluated using Pearson correlation analysis. The relationships between predictive factors of PPDs and SCL-90 were evaluated using Pearson correlation analysis.
Results: With the SCL-90 cutoff value of 160, the incidence of postpartum psychiatric disorders was 9.17% among Chinese urban women. The univariate and multivariate logistic regression analyses indicated that age ≤ 25 years old (OR = 10.07, 95%CI = 1.83-55.33), prenatal mood disorder (OR = 4.12, 95%CI = 1.99-8.53), invasive prenatal diagnostic procedures (OR = 4.39, 95%CI = 1.16-16.56), poor relationship with husband (OR = 2.86, 95%CI = 1.58-5.16) and poor relationship with mother-in-law (OR = 5.10, 95%CI = 2.70-9.64) were significantly associated with PPDs. A nomogram prediction model for PPDs was further constructed based on these five independent risk factors, and the area under the receiver operating characteristic curve (AUC) of the nomogram model was 0.823 (95% CI = 0.781-0.865). The calibration curves showed remarkable accuracy of the nomogram and the DCA exhibited high clinical net benefit of the nomogram. Besides, we also explored the relationships between the five risk factors and different symptom dimensions of PPDs and found that the five risk factors were almost associated with increased levels of all symptom dimensions.
Conclusions: Five psychosocial risk factors for PPDs were identified in Chinese women and the nomogram prediction model constructed based on these five risk factors could predict the risk of PPDs intuitively and individually. Systematic screening these risk factors and further conducting psychosocial interventions earlier during the pregnancy period are crucial to prevent PPDs. For future research, we intend to incorporate additional risk factors, including blood biomarkers and facial expression indicators, to refine our risk model.
{"title":"Risk factors and prediction model for postpartum psychiatric disorders: a retrospective cohort study of 1418 Chinese women from 2020 to 2022.","authors":"Wenxi Chen, Huan Ge, Jing Cong, Wenjie Zhou, Xiaoxia Chang, Xiaojie Quan, Jing Xia, Xincheng Tao, Danhua Pu, Jie Wu","doi":"10.1080/14767058.2024.2438756","DOIUrl":"10.1080/14767058.2024.2438756","url":null,"abstract":"<p><strong>Background: </strong>Postpartum psychiatric disorders (PPDs) have been deemed as a significant public health concern, affecting both maternal health and family dynamics. This study aimed to examine the current status of PPDs, identify the potential risk factors of PPDs, and further develop a clinical nomogram model for predicting PPDs in Chinese women.</p><p><strong>Method: </strong>In this retrospective cohort study, 1418 postpartum women attending the routine postpartum examination at the 42nd day after delivery in Jiangsu Women and Children Health Hospital were recruited as participants from December 2020 to December 2022. The Symptom Checklist-90 (SCL-90) was utilized to assess the status of postpartum psychiatric disorders. A prediction model was constructed by multivariate logistic regression and presented as a nomogram. The performance of nomogram was measured by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA). The relationships between predictive factors of PPDs and SCL-90 were also evaluated using Pearson correlation analysis. The relationships between predictive factors of PPDs and SCL-90 were evaluated using Pearson correlation analysis.</p><p><strong>Results: </strong>With the SCL-90 cutoff value of 160, the incidence of postpartum psychiatric disorders was 9.17% among Chinese urban women. The univariate and multivariate logistic regression analyses indicated that age ≤ 25 years old (OR = 10.07, 95%CI = 1.83-55.33), prenatal mood disorder (OR = 4.12, 95%CI = 1.99-8.53), invasive prenatal diagnostic procedures (OR = 4.39, 95%CI = 1.16-16.56), poor relationship with husband (OR = 2.86, 95%CI = 1.58-5.16) and poor relationship with mother-in-law (OR = 5.10, 95%CI = 2.70-9.64) were significantly associated with PPDs. A nomogram prediction model for PPDs was further constructed based on these five independent risk factors, and the area under the receiver operating characteristic curve (AUC) of the nomogram model was 0.823 (95% CI = 0.781-0.865). The calibration curves showed remarkable accuracy of the nomogram and the DCA exhibited high clinical net benefit of the nomogram. Besides, we also explored the relationships between the five risk factors and different symptom dimensions of PPDs and found that the five risk factors were almost associated with increased levels of all symptom dimensions.</p><p><strong>Conclusions: </strong>Five psychosocial risk factors for PPDs were identified in Chinese women and the nomogram prediction model constructed based on these five risk factors could predict the risk of PPDs intuitively and individually. Systematic screening these risk factors and further conducting psychosocial interventions earlier during the pregnancy period are crucial to prevent PPDs. For future research, we intend to incorporate additional risk factors, including blood biomarkers and facial expression indicators, to refine our risk model.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2438756"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2024-12-10DOI: 10.1080/14767058.2025.2440150
{"title":"Statement of Retraction: A sandwich technique (N&H variation technique) to reduce blood loss during cesarean delivery for complete placenta previa: a randomized controlled trial.","authors":"","doi":"10.1080/14767058.2025.2440150","DOIUrl":"https://doi.org/10.1080/14767058.2025.2440150","url":null,"abstract":"","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2440150"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2024-12-25DOI: 10.1080/14767058.2024.2440774
Linyan He, Xihong Zhou, Jiajun Tang, Min Yao, Li Peng, Sai Liu
Background: Excessive Gestational Weight Gain is a global public health problem with serious and long-term effects on maternal and offspring health. Early identification of at-risk groups and interventions is crucial for controlling weight gain and reducing the prevalence of excessive gestational weight gain. Currently, tools for predicting the risk of excessive gestational weight gain are lacking in China. This study aimed to develop a risk-prediction model and screening tool to identify high-risk groups in the early stages.
Methods: A total of 306 pregnant women were randomly selected who underwent regular obstetric checkups at a tertiary-level hospital in China between January and March 2023. Logistic regression analysis was used to construct the risk-prediction model. The goodness of fit of the model was assessed using the Hosmer-Lemeshow test, and the predictive performance was evaluated using the area under the receiver operating characteristic (ROC) curve, calibration plots, and k-fold cross-validation. R4.3.1 software was used to create a nomogram.
Results: The prevalence of excessive gestational weight gain was 50.32%. Logistic regression analysis revealed that pre-pregnancy overweight (OR = 2.563, 95% CI: 1.043-6.299), obesity (OR = 4.116, 95% CI: 1.396-12.141), eating in front of a screen (OR = 6.230, 95% CI: 2.753 - 14.097); frequency of weekly consumption of sugar-sweetened beverages/desserts/western fast food (OR = 1.948, 95% CI: 1.363-2.785); and pregnancy body image (OR = 1.030, 95% CI: 1.014-1.047) were risk factors for excessive gestational weight gain. Parity (OR = 0.452, 95% CI: 0.275 - 0.740), protective motivation to manage pregnancy body mass (OR = 0.979, 95% CI: 0.958-1), and the time of daily moderate-intensity physical activity (OR = 0.228, 95% CI: 0.113-0.461) were protective factors against excessive gestational weight gain. The area under the ROC curve of the model was 0.885, the mean value of ten-fold cross-validation was 0.857 for AUC.
Conclusion: The nomogram model developed in this study has a good degree of discrimination and calibration, providing a valuable basis for early identification and precise intervention in individuals at risk of excessive gestational weight gain.
{"title":"Risk prediction of excessive gestational weight gain based on a nomogram model: a prospective observational study in China.","authors":"Linyan He, Xihong Zhou, Jiajun Tang, Min Yao, Li Peng, Sai Liu","doi":"10.1080/14767058.2024.2440774","DOIUrl":"10.1080/14767058.2024.2440774","url":null,"abstract":"<p><strong>Background: </strong>Excessive Gestational Weight Gain is a global public health problem with serious and long-term effects on maternal and offspring health. Early identification of at-risk groups and interventions is crucial for controlling weight gain and reducing the prevalence of excessive gestational weight gain. Currently, tools for predicting the risk of excessive gestational weight gain are lacking in China. This study aimed to develop a risk-prediction model and screening tool to identify high-risk groups in the early stages.</p><p><strong>Methods: </strong>A total of 306 pregnant women were randomly selected who underwent regular obstetric checkups at a tertiary-level hospital in China between January and March 2023. Logistic regression analysis was used to construct the risk-prediction model. The goodness of fit of the model was assessed using the Hosmer-Lemeshow test, and the predictive performance was evaluated using the area under the receiver operating characteristic (ROC) curve, calibration plots, and k-fold cross-validation. R4.3.1 software was used to create a nomogram.</p><p><strong>Results: </strong>The prevalence of excessive gestational weight gain was 50.32%. Logistic regression analysis revealed that pre-pregnancy overweight (OR = 2.563, 95% CI: 1.043-6.299), obesity (OR = 4.116, 95% CI: 1.396-12.141), eating in front of a screen (OR = 6.230, 95% CI: 2.753 - 14.097); frequency of weekly consumption of sugar-sweetened beverages/desserts/western fast food (OR = 1.948, 95% CI: 1.363-2.785); and pregnancy body image (OR = 1.030, 95% CI: 1.014-1.047) were risk factors for excessive gestational weight gain. Parity (OR = 0.452, 95% CI: 0.275 - 0.740), protective motivation to manage pregnancy body mass (OR = 0.979, 95% CI: 0.958-1), and the time of daily moderate-intensity physical activity (OR = 0.228, 95% CI: 0.113-0.461) were protective factors against excessive gestational weight gain. The area under the ROC curve of the model was 0.885, the mean value of ten-fold cross-validation was 0.857 for AUC.</p><p><strong>Conclusion: </strong>The nomogram model developed in this study has a good degree of discrimination and calibration, providing a valuable basis for early identification and precise intervention in individuals at risk of excessive gestational weight gain.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2440774"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-01-02DOI: 10.1080/14767058.2024.2443968
Petra Psenkova, M Veliskova, D Dzubinska, I Waczulikova, M Tedla, P Peskovicova, J Zahumensky
Purpose: The main objective of this study was to assess the impact of a composite quality improvement intervention on mode of birth in nullipara term singleton vertex (NTSVs).
Material and methods: This was an ambidirectional study following the implementation of the intervention to reduce cesarean section rate in NSTV by comparing two birth cohorts, pre-composite quality improvement intervention cohort (January 2013-December 2015) and post-composite quality improvement intervention cohort (January 2018-December 2020).
Results: In the studied periods, there was a total of 7713 NTSV births. Compared to pre-composite quality improvement intervention, there was a post-composite quality improvement intervention reduction in NTSV cesarean section rate from 30.89% to 13.31% (p < 0.0001). Obstetric and non-obstetric indications for elective cesarean sections decreased from 5.52% to 1.04% (p < 0.0001) and from 4.82% to 0.52% (p < 0.0001), respectively. The frequency of emergency cesarean sections in this group decreased from 20.56% to 11.75% (p < 0.0001), especially those performed for failure to progress in labor (from 13.69% to 7.30%; p < 0.0001). There has been a rising trend with regards to maternal age. However, the proportion of mothers aged 35 years and more giving birth by cesarean section reduced from 46.94% to 20.28%. These reductions in cesarean section rates occurred without any negative impact on core fetal outcomes.
Conclusions: This quality improvement study demonstrates that it is feasible to significantly reduce cesarean section rate in NTSV by adopting specific composite measures. However, this requires the understanding of the inherent problems and barriers within the unit and the involvement of all stake holders.
目的:本研究的主要目的是评估综合质量改善干预对无产单胎顶点(ntsv)出生方式的影响。材料与方法:本研究是一项实施降低非stv剖宫产率干预后的双向研究,通过比较两个出生队列,复合前质量改善干预队列(2013年1月- 2015年12月)和复合后质量改善干预队列(2018年1月- 2020年12月)。结果:研究期间共发生NTSV分娩7713例。与复合前质量改善干预相比,复合后质量改善干预将NTSV剖宫产率从30.89%降低至13.31% (p p p p p)。结论:本质量改善研究表明,通过采取针对性的复合措施,显著降低NTSV剖宫产率是可行的。然而,这需要了解单位内部固有的问题和障碍,以及所有利益相关者的参与。
{"title":"Mode of birth in nulliparous term singleton pregnancies in vertex presentation before and after implementation of an evidence-based intervention: quality-improvement study.","authors":"Petra Psenkova, M Veliskova, D Dzubinska, I Waczulikova, M Tedla, P Peskovicova, J Zahumensky","doi":"10.1080/14767058.2024.2443968","DOIUrl":"https://doi.org/10.1080/14767058.2024.2443968","url":null,"abstract":"<p><strong>Purpose: </strong>The main objective of this study was to assess the impact of a composite quality improvement intervention on mode of birth in nullipara term singleton vertex (NTSVs).</p><p><strong>Material and methods: </strong>This was an ambidirectional study following the implementation of the intervention to reduce cesarean section rate in NSTV by comparing two birth cohorts, pre-composite quality improvement intervention cohort (January 2013-December 2015) and post-composite quality improvement intervention cohort (January 2018-December 2020).</p><p><strong>Results: </strong>In the studied periods, there was a total of 7713 NTSV births. Compared to pre-composite quality improvement intervention, there was a post-composite quality improvement intervention reduction in NTSV cesarean section rate from 30.89% to 13.31% (<i>p</i> < 0.0001). Obstetric and non-obstetric indications for elective cesarean sections decreased from 5.52% to 1.04% (<i>p</i> < 0.0001) and from 4.82% to 0.52% (<i>p</i> < 0.0001), respectively. The frequency of emergency cesarean sections in this group decreased from 20.56% to 11.75% (<i>p</i> < 0.0001), especially those performed for failure to progress in labor (from 13.69% to 7.30%; <i>p</i> < 0.0001). There has been a rising trend with regards to maternal age. However, the proportion of mothers aged 35 years and more giving birth by cesarean section reduced from 46.94% to 20.28%. These reductions in cesarean section rates occurred without any negative impact on core fetal outcomes.</p><p><strong>Conclusions: </strong>This quality improvement study demonstrates that it is feasible to significantly reduce cesarean section rate in NTSV by adopting specific composite measures. However, this requires the understanding of the inherent problems and barriers within the unit and the involvement of all stake holders.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2443968"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-04-28DOI: 10.1080/14767058.2025.2493731
Maria Goretti Policarpo Barreto, Cláudia Silva, Renata Policarpo Barreto, Roberta Policarpo Barreto, Lara Moreira Teles de Vasconcelos, Maria Conceição Manso
Objective: Even with all the worldwide effort in the care of pregnant women and newborns in the last 10 years, perinatal asphyxia remains a crucial public health problem worldwide, being responsible for the high rates of morbidity and mortality in term and preterm newborns. In this perspective, research was carried out which aimed to investigate the prevalence and analyze the environmental and maternal-fetal risk factors associated with perinatal asphyxia.
Methods: This cohort study (2013-2018), corresponding to six years, was conducted in Fortaleza, Ceará, Brazil. The study involved 480 postpartum women living in a capital in the Northeast of Brazil, whose newborns were admitted to the neonatal intensive care unit of a private referral hospital for high-risk pregnancies. Perinatal asphyxia in live births was taken as the dependent variable. To identify risk factors associated with perinatal asphyxia, bivariate and multivariate analyses were performed.
Results: The research showed a high prevalence of perinatal asphyxia. The final multivariate analysis showed a significant association between perinatal asphyxia and eclampsia and complications in labor (p < 0.05), these being preventable causes of this outcome. The research demonstrated a high prevalence of perinatal asphyxia and a significant association between perinatal asphyxia and complications in labor, eclampsia, and cesarean sections (p < 0.05), being preventable causes of this outcome.
Conclusion: The study gave greater visibility to prenatal care, and understanding complications during pregnancy and childbirth care. The publication of the results signaled to managers the need to implement public and private politics to face this problem, which promoted improvements in the living conditions of the population and the care of pregnant women, to reduce the births of babies with perinatal asphyxia, consequently, reducing neonatal and infant mortality.
{"title":"Perinatal asphyxia-prevalence and risk factors: a cohort study in a neonatal intensive care unit in northeast Brazil.","authors":"Maria Goretti Policarpo Barreto, Cláudia Silva, Renata Policarpo Barreto, Roberta Policarpo Barreto, Lara Moreira Teles de Vasconcelos, Maria Conceição Manso","doi":"10.1080/14767058.2025.2493731","DOIUrl":"https://doi.org/10.1080/14767058.2025.2493731","url":null,"abstract":"<p><strong>Objective: </strong>Even with all the worldwide effort in the care of pregnant women and newborns in the last 10 years, perinatal asphyxia remains a crucial public health problem worldwide, being responsible for the high rates of morbidity and mortality in term and preterm newborns. In this perspective, research was carried out which aimed to investigate the prevalence and analyze the environmental and maternal-fetal risk factors associated with perinatal asphyxia.</p><p><strong>Methods: </strong>This cohort study (2013-2018), corresponding to six years, was conducted in Fortaleza, Ceará, Brazil. The study involved 480 postpartum women living in a capital in the Northeast of Brazil, whose newborns were admitted to the neonatal intensive care unit of a private referral hospital for high-risk pregnancies. Perinatal asphyxia in live births was taken as the dependent variable. To identify risk factors associated with perinatal asphyxia, bivariate and multivariate analyses were performed.</p><p><strong>Results: </strong>The research showed a high prevalence of perinatal asphyxia. The final multivariate analysis showed a significant association between perinatal asphyxia and eclampsia and complications in labor (<i>p</i> < 0.05), these being preventable causes of this outcome. The research demonstrated a high prevalence of perinatal asphyxia and a significant association between perinatal asphyxia and complications in labor, eclampsia, and cesarean sections (<i>p</i> < 0.05), being preventable causes of this outcome.</p><p><strong>Conclusion: </strong>The study gave greater visibility to prenatal care, and understanding complications during pregnancy and childbirth care. The publication of the results signaled to managers the need to implement public and private politics to face this problem, which promoted improvements in the living conditions of the population and the care of pregnant women, to reduce the births of babies with perinatal asphyxia, consequently, reducing neonatal and infant mortality.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2493731"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-05-13DOI: 10.1080/14767058.2025.2501697
Anna O Menshykova, Dmytro O Dobryanskyy
Objective: Bronchopulmonary dysplasia (BPD) remains a common pathology in very preterm infants. The risk of complications increases with the severity of the disease.The study aimed to determine the factors affecting the formation of moderate/severe BPD in the modern population of very preterm infants.
Methods: Data from 201 very low birth weight infants < 32 weeks of gestation were used in a retrospective cohort study. Infants were retrospectively divided into two groups based on the type of respiratory support at 36 weeks of postmenstrual age (PMA) - mild BPD (133 infants) and moderate/severe BPD (68 infants). The influence of major perinatal risk factors, neonatal morbidity, and medical interventions on the development of moderate/severe BPD was assessed.
Results: The groups were different in the incidence of intrauterine growth restriction (5% vs. 15%; p = 0.02), maternal hypertension (5% vs. 18%; p = 0.004), cesarean section (29% vs. 43%; p = 0.04), severe intraventricular hemorrhage (9% vs. 19%; p = 0.04), and retinopathy of prematurity (5% vs. 18%; p = 0.002), as well as in need for chest compressions during resuscitation at birth (2% vs. 9%; p = 0.01) for mild and moderate/severe BPD, respectively. Infants in the moderate/severe BPD group had lower Apgar scores at 1 and 5 min, required longer mechanical ventilation (220 (10-1904) hours vs. 72 (1-614) hours; p < 0.0001), CPAP duration (456 (16-1320) hours vs. 278 (10-1200) hours; p = 0.0002), oxygen supply (50 (3-146) days vs. 29 (2-68) days; p < 0.0001), as well as antibacterial therapy (61 (16-177) days vs. 52 (9-121) days; p = 0.0001) and hospital stay (109 (59-321) days vs. 85 (45-205) days; p < 0.0001). Infants with more severe BPD were also significantly more likely to die after reaching the PMA of 36 weeks (12% vs. 1%; p = 0.0003).According to the multivariable logistic regression analysis, the moderate/severe BPD was reliably and independently determined by maternal hypertension (aOR 4.53, 95% CI 1.48-13.91) and genitourinary infections (aOR 4.41, 95% CI 1.41-13.78), as well as the duration of CPAP (aOR 1.002, 95% CI 1.001-1.004) and mechanical ventilation (aOR 1.006, 95% CI 1.004-1.009).
Conclusions: Duration of respiratory support is the main risk factor that determines the development of moderate/severe BPD in the modern population of very preterm infants. Maternal hypertension and genitourinary infections may influence the severity of lung injury.
目的:支气管肺发育不良(BPD)仍然是非常早产儿的常见病理。并发症的风险随着疾病的严重程度而增加。该研究旨在确定影响现代极早产儿中中度/重度BPD形成的因素。方法:回顾性队列研究采用201例妊娠期< 32周的极低出生体重儿的数据。根据经后36周(PMA)呼吸支持的类型,将婴儿回顾性分为两组——轻度BPD(133名婴儿)和中度/重度BPD(68名婴儿)。评估主要围产期危险因素、新生儿发病率和医疗干预对中重度BPD发展的影响。结果:两组在宫内生长受限发生率上存在差异(5% vs. 15%;P = 0.02),产妇高血压(5% vs. 18%;P = 0.004),剖宫产(29% vs. 43%;P = 0.04),严重脑室内出血(9% vs. 19%;P = 0.04),早产儿视网膜病变(5% vs. 18%;P = 0.002),以及出生时复苏时需要胸外按压(2% vs. 9%;p = 0.01),分别为轻度和中度/重度BPD。中度/重度BPD组婴儿在1分钟和5分钟时Apgar评分较低,需要更长的机械通气时间(220(10-1904)小时对72(1-614)小时;P P = 0.0002),供氧(50(3-146)天vs. 29(2-68)天;P = 0.0001)和住院时间(109(59-321)天和85(45-205)天;p = 0.0003)。根据多变量logistic回归分析,产妇高血压(aOR 4.53, 95% CI 1.48-13.91)和泌尿生殖系统感染(aOR 4.41, 95% CI 1.41-13.78)以及CPAP持续时间(aOR 1.002, 95% CI 1.001-1.004)和机械通气(aOR 1.006, 95% CI 1.004-1.009)可靠且独立地决定了中/重度BPD。结论:呼吸支持持续时间是决定现代极早产儿中重度BPD发展的主要危险因素。产妇高血压和泌尿生殖系统感染可能影响肺损伤的严重程度。
{"title":"Risk factors of bronchopulmonary dysplasia depending on the severity of the disease in very preterm infants.","authors":"Anna O Menshykova, Dmytro O Dobryanskyy","doi":"10.1080/14767058.2025.2501697","DOIUrl":"https://doi.org/10.1080/14767058.2025.2501697","url":null,"abstract":"<p><strong>Objective: </strong>Bronchopulmonary dysplasia (BPD) remains a common pathology in very preterm infants. The risk of complications increases with the severity of the disease.The study aimed to determine the factors affecting the formation of moderate/severe BPD in the modern population of very preterm infants.</p><p><strong>Methods: </strong>Data from 201 very low birth weight infants < 32 weeks of gestation were used in a retrospective cohort study. Infants were retrospectively divided into two groups based on the type of respiratory support at 36 weeks of postmenstrual age (PMA) - mild BPD (133 infants) and moderate/severe BPD (68 infants). The influence of major perinatal risk factors, neonatal morbidity, and medical interventions on the development of moderate/severe BPD was assessed.</p><p><strong>Results: </strong>The groups were different in the incidence of intrauterine growth restriction (5% vs. 15%; <i>p</i> = 0.02), maternal hypertension (5% vs. 18%; <i>p</i> = 0.004), cesarean section (29% vs. 43%; <i>p</i> = 0.04), severe intraventricular hemorrhage (9% vs. 19%; <i>p</i> = 0.04), and retinopathy of prematurity (5% vs. 18%; <i>p</i> = 0.002), as well as in need for chest compressions during resuscitation at birth (2% vs. 9%; <i>p</i> = 0.01) for mild and moderate/severe BPD, respectively. Infants in the moderate/severe BPD group had lower Apgar scores at 1 and 5 min, required longer mechanical ventilation (220 (10-1904) hours vs. 72 (1-614) hours; <i>p</i> < 0.0001), CPAP duration (456 (16-1320) hours vs. 278 (10-1200) hours; <i>p</i> = 0.0002), oxygen supply (50 (3-146) days vs. 29 (2-68) days; <i>p</i> < 0.0001), as well as antibacterial therapy (61 (16-177) days vs. 52 (9-121) days; <i>p</i> = 0.0001) and hospital stay (109 (59-321) days vs. 85 (45-205) days; <i>p</i> < 0.0001). Infants with more severe BPD were also significantly more likely to die after reaching the PMA of 36 weeks (12% vs. 1%; <i>p</i> = 0.0003).According to the multivariable logistic regression analysis, the moderate/severe BPD was reliably and independently determined by maternal hypertension (aOR 4.53, 95% CI 1.48-13.91) and genitourinary infections (aOR 4.41, 95% CI 1.41-13.78), as well as the duration of CPAP (aOR 1.002, 95% CI 1.001-1.004) and mechanical ventilation (aOR 1.006, 95% CI 1.004-1.009).</p><p><strong>Conclusions: </strong>Duration of respiratory support is the main risk factor that determines the development of moderate/severe BPD in the modern population of very preterm infants. Maternal hypertension and genitourinary infections may influence the severity of lung injury.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2501697"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-02-23DOI: 10.1080/14767058.2025.2463401
Qiu-Min Yang, Chu Zhang, Yun-Yun Zhang, Cai-Ning Liu
Purpose: Placenta accreta (PA) significantly increases the risk of life-threatening maternal outcomes, and its rising prevalence, driven by the increase in cesarean deliveries, underscores the need for precise diagnostic tools to improve clinical management and outcomes. This study aims to evaluate the advanced diagnostic capabilities of prenatal ultrasound and magnetic resonance imaging (MRI) in the detection of PA, a severe obstetric complication characterized by abnormal adherence of the placenta to the myometrium.
Materials and methods: The study utilized a review of current literature and clinical studies to assess the diagnostic accuracy and clinical utility of ultrasound and MRI in identifying PA. Both imaging modalities were evaluated for their ability to assess the depth and extent of placental invasion, as well as their complementary roles in prenatal diagnosis. The experimental system included detailed imaging protocols for ultrasound and MRI, focusing on placental and uterine structures, and their application in real-world clinical settings.
Results: The findings demonstrate that ultrasound and MRI are highly effective in diagnosing PA, with each modality offering unique advantages. Ultrasound is widely accessible and serves as the first-line diagnostic tool, providing detailed visualization of placental adherence and vascular patterns. MRI, on the other hand, offers superior soft tissue contrast and is particularly valuable in complex cases or when ultrasound findings are inconclusive. Together, these imaging techniques enable accurate evaluation of placental invasion, facilitating timely and targeted prenatal interventions. The study also highlights the potential for improved maternal and fetal outcomes through early diagnosis and optimized pregnancy management.
Conclusions: Prenatal ultrasound and MRI are indispensable tools in the diagnosis and management of placenta accreta, offering complementary insights that enhance diagnostic precision. Their combined use allows for detailed assessment of placental and uterine structures, guiding clinical decision-making and improving outcomes for both mothers and infants. Future advancements in imaging technology and research hold promise for further enhancing diagnostic accuracy and expanding clinical applications, ultimately contributing to safer and more effective care for patients with PA.
{"title":"Perspective in diagnostic accuracy of prenatal ultrasound and MRI for placenta accreta.","authors":"Qiu-Min Yang, Chu Zhang, Yun-Yun Zhang, Cai-Ning Liu","doi":"10.1080/14767058.2025.2463401","DOIUrl":"10.1080/14767058.2025.2463401","url":null,"abstract":"<p><strong>Purpose: </strong>Placenta accreta (PA) significantly increases the risk of life-threatening maternal outcomes, and its rising prevalence, driven by the increase in cesarean deliveries, underscores the need for precise diagnostic tools to improve clinical management and outcomes. This study aims to evaluate the advanced diagnostic capabilities of prenatal ultrasound and magnetic resonance imaging (MRI) in the detection of PA, a severe obstetric complication characterized by abnormal adherence of the placenta to the myometrium.</p><p><strong>Materials and methods: </strong>The study utilized a review of current literature and clinical studies to assess the diagnostic accuracy and clinical utility of ultrasound and MRI in identifying PA. Both imaging modalities were evaluated for their ability to assess the depth and extent of placental invasion, as well as their complementary roles in prenatal diagnosis. The experimental system included detailed imaging protocols for ultrasound and MRI, focusing on placental and uterine structures, and their application in real-world clinical settings.</p><p><strong>Results: </strong>The findings demonstrate that ultrasound and MRI are highly effective in diagnosing PA, with each modality offering unique advantages. Ultrasound is widely accessible and serves as the first-line diagnostic tool, providing detailed visualization of placental adherence and vascular patterns. MRI, on the other hand, offers superior soft tissue contrast and is particularly valuable in complex cases or when ultrasound findings are inconclusive. Together, these imaging techniques enable accurate evaluation of placental invasion, facilitating timely and targeted prenatal interventions. The study also highlights the potential for improved maternal and fetal outcomes through early diagnosis and optimized pregnancy management.</p><p><strong>Conclusions: </strong>Prenatal ultrasound and MRI are indispensable tools in the diagnosis and management of placenta accreta, offering complementary insights that enhance diagnostic precision. Their combined use allows for detailed assessment of placental and uterine structures, guiding clinical decision-making and improving outcomes for both mothers and infants. Future advancements in imaging technology and research hold promise for further enhancing diagnostic accuracy and expanding clinical applications, ultimately contributing to safer and more effective care for patients with PA.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2463401"},"PeriodicalIF":1.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}